Back
Nuveen S&P 500 Buy-Write Income Fund Vs. GeneDx Holdings Industry Stock Comparison
Sell
50
BXMX
Nuveen S&P 500 Buy-Write Income Fund
Last Price:
$13.88
Seasonality Move:
-0.04%
Buy
80
WGS
GeneDx Holdings
Last Price:
$94.54
Seasonality Move:
71.65%
Sell
50
Nuveen S&P 500 Buy-Write Income Fund (BXMX)
is a Sell
Is Nuveen S&P 500 Buy-Write Income Fund a Buy, Sell or Hold?
-
The current Nuveen S&P 500 Buy-Write Income Fund [BXMX] share price is $13.84. The Score for BXMX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BXMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
GeneDx Holdings (WGS)
is a Buy
Is GeneDx Holdings a Buy, Sell or Hold?
-
The current GeneDx Holdings [WGS] share price is $97.04. The Score for WGS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
WGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BXMX Stock Price Chart
What is Nuveen S&P 500 Buy-Write Income Fund's stock price today?
-
The Nuveen S&P 500 Buy-Write Income Fund share price today is $13.84The current trend is relatively stagnant and BXMX is experiencing selling pressure, which indicates risk of future bearish movement.
WGS Stock Price Chart
What is GeneDx Holdings's stock price today?
-
The GeneDx Holdings share price today is $97.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BXMX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 46.92 | Sell |
| Chaikin Money Flow: | -123444 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.8 - 14.16) | Sell |
| Bollinger Bands (100): | (13.47 - 13.97) | Buy |
WGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.41 | Buy |
| Relative Strength Index (14 RSI): | 74.53 | Buy |
| Chaikin Money Flow: | 1089365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.97 - 83.29) | Buy |
| Bollinger Bands (100): | (40.46 - 78.4) | Buy |
BXMX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.93 | Sell |
| 20-day SMA: | 13.94 | Sell |
| 50-day SMA: | 13.9 | Sell |
| 200-day SMA: | 13.44 | Buy |
| 8-day EMA: | 13.89 | Sell |
| 20-day EMA: | 13.92 | Sell |
| 50-day EMA: | 13.88 | Sell |
| 200-day EMA: | 13.53 | Buy |
WGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 82.05 | Buy |
| 20-day SMA: | 78.26 | Buy |
| 50-day SMA: | 76.51 | Buy |
| 200-day SMA: | 40.84 | Buy |
| 8-day EMA: | 84.27 | Buy |
| 20-day EMA: | 80.04 | Buy |
| 50-day EMA: | 73.57 | Buy |
| 200-day EMA: | 47.46 | Buy |
Nuveen S&P 500 Buy-Write Income Fund Earnings Growth & BXMX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
GeneDx Holdings Earnings Growth & WGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.86 per share, and an increase next year of $0.92 per share.
Nuveen S&P 500 Buy-Write Income Fund Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
GeneDx Holdings Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||